Primary care physicians’ perspectives on Veterans who obtain prescription opioids from multiple healthcare systems
DOI:
https://doi.org/10.5055/jom.2019.0502Keywords:
primary care, opioids, pain management, Veterans, dual useAbstract
Objective: To characterize primary care physicians’ (PCPs’) perceptions of the reasons patients receive opioid medications from both VA and non-VA healthcare systems.
Design: Qualitative.
Setting: Department of Veterans Affairs (VA).
Participants: Forty-two VA PCPs who prescribed opioids to at least 15 patients and who practiced in Massachusetts, Illinois, or Pennsylvania.
Methods: Thirty-minute, semistructured telephone interviews were conducted in 2016, addressing topics regarding PCPs’ experiences and perspectives on patients who use both VA and non-VA healthcare systems to obtain prescription opioids. The analysis focused on two questions: attributes that PCPs believe characterize dual-use patients and reasons that PCPs believe patients obtain opioids from both VA and non-VA sources.
Results: PCPs identified multiple attributes of, and reasons for, patients obtaining opioid medications from both VA and non-VA healthcare systems, including pain issues, opioid misuse, having healthcare managed through multiple healthcare systems, and transferring care between systems. More than half of the PCPs identified addiction and diversion as key attributes and reasons why patients obtain prescription opioids from multiple sources. PCPs also identified several behavioral and psychological factors as attributes of these patients.
Conclusions: PCPs within the VA have varying perceptions of patients obtaining opioid medications from multiple healthcare systems, with pain complaints and opioid misuse as the primary themes. This knowledge about PCPs’ perceptions can be incorporated into interventions to better manage pain and prescription opioid use by VA patients.
References
Centers for Disease Control and Prevention: Annual Surveillance Report of Drug-Related Risks and Outcomes—United States, 2017. Washington, DC: Centers for Disease Control and Prevention, US Department of Health and Human Services, 2017. Surveillance Special Report 1. Available at https://www.cdc.gov/drugoverdose/pdf/pubs/2017pdf. Accessed February 5, 2018.
Madadi P, Persaud N: Suicide by means of opioid overdose in patients with chronic pain. Curr Pain Headache Rep. 2014; 18: 460.
Mendelson J, Flower K, Pletcher MJ, et al.: Addiction to prescription opioids: Characteristics of the emerging epidemic and treatment with buprenorphine. Exp Clin Psychopharmacol. 2008; 16: 435-441.
Bohnert AS, Valenstein M, Bair MJ, et al.: Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011; 305: 1315-1321.
Okie S: A flood of opioids, a rising tide of deaths. N Engl J Med. 2010; 363: 1981-1985.
Paulozzi LJ, Budnitz DS, Xi Y: Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf. 2006; 15: 618-627.
Dobscha SK, Corson K, Flores JA, et al.: Veterans affairs primary care clinicians’ attitudes toward chronic pain and correlates of opioid prescribing rates. Pain Med. 2008; 9: 564-571.
Jamison RN, Sheehan KA, Scanlan E, et al.: Beliefs and attitudes about opioid prescribing and chronic pain management: Survey of primary care providers. J Opioid Manag. 2014; 10: 375-382.
Upshur CC, Luckmann RS, Savageau JA: Primary care provider concerns about management of chronic pain in community clinic populations. J Gen Intern Med. 2006; 21: 652-655.
Wolfert MZ, Gilson AM, Dahl JL, et al.: Opioid analgesics for pain control: Wisconsin physicians’ knowledge, beliefs, attitudes, and prescribing practices. Pain Med. 2010; 11: 425-434.
Jena AB, Goldman D, Weaver L, et al.: Opioid prescribing by multiple providers in Medicare: Retrospective observational study of insurance claims. BMJ. 2014; 348: g1393.
Wilsey BL, Fishman SM, Gilson AM, et al.: Profiling multiple provider prescribing of opioids, benzodiazepines, stimulants, and anorectics. Drug Alcohol Depend. 2010; 112: 99-106.
Gellad WF, Thorpe JM, Zhao X, et al.: Impact of dual use of Department of Veterans Affairs and Medicare Part D drug benefits on potentially unsafe opioid use. Am J Public Health. 2018; 108: 248-255.
Col SE, Caykoylu A, Karakas Ugurlu G, et al.: Factors affecting treatment compliance in patients with bipolar I disorder during prophylaxis: A study from Turkey. Gen Hosp Psychiatry. 2014; 36: 208-213.
Gellad WF, Cunningham FE, Good CB, et al.: Pharmacy use in the first year of the Veterans choice program: A mixed-methods evaluation. Med Care. 2017; 55(suppl 7 suppl 1): S26-S32.
Reisman RM, Shenoy PJ, Atherly AJ, et al.: Prescription opioid usage and abuse relationships: An evaluation of state prescription drug monitoring program efficacy. Subst Abuse. 2009; 3: 41-51.
Guest G, Bunce A, Johnson L: How many interviews are enough?: An experiment with data saturation and variability. Field Methods. 2006; 18: 59-82.
Radomski TR, Bixler FR, Zickmund SL, et al.: Physicians’ perspectives regarding prescription drug monitoring program use within the Department of Veterans Affairs: A multi-state qualitative study. J Gen Intern Med. 2018; 33: 1253-1259.
Tong A, Sainsbury P, Craig J: Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007; 19: 349-357.
Madon S: What do people believe about gay males? A study of stereotype content and strength. Sex Roles. 1997; 37: 663-685.
Crabtree BF, Miller WL (eds.): Doing Qualitative Research. 2nd ed. Thousand Oaks, CA: Sage Publications, Inc., 1999.
Barnett JM: Review Jacqueline M. Barnett: “Doing qualitative research” (Crabtree & Miller 1999). Forum Qual Soc Res. 2002; 3: Article 3.
Silverman D: Doing Qualitative Research: A Practical Handbook. London: Sage Publications, 2005.
McHugh ML: Interrater reliability: The kappa statistic. Biochem Med (Zagreb). 2012; 22: 276-282.
Kennedy-Hendricks A, Busch SH, McGinty EE, et al.: Primary care physicians’ perspectives on the prescription opioid epidemic. Drug Alcohol Depend. 2016; 165: 61-70.
Ebbert JO, Philpot LM, Clements CM, et al.: Attitudes, beliefs, practices, and concerns among clinicians prescribing opioids in a large academic institution. Pain Med. 2018; 19: 1790-1798.
Lin DH, Lucas E, Murimi IB, et al.: Physician attitudes and experiences with Maryland’s prescription drug monitoring program (PDMP). Addiction. 2017; 112: 311-319.
Wenghofer EF, Wilson L, Kahan M, et al.: Survey of Ontario primary care physicians’ experiences with opioid prescribing. Can Fam Physician. 2011; 57: 324-332.
Gellad WF, Good CB, Shulkin DJ: Addressing the opioid epidemic in the United States: Lessons from the Department of Veterans Affairs. JAMA Intern Med. 2017; 177: 611-612.
Published
How to Cite
Issue
Section
License
Copyright 2005-2024, Weston Medical Publishing, LLC
All Rights Reserved
